Rodriguez Peñaranda Natali, di Bello Francesco, Marmiroli Andrea, Falkenbach Fabian, Longoni Mattia, Le Quynh Chi, Goyal Jordan A, Tian Zhe, Saad Fred, Shariat Shahrokh F, Longo Nicola, de Cobelli Ottavio, Graefen Markus, Briganti Alberto, Chun Felix K H, Stella Giuseppe, Piro Adele, Puliatti Stefano, Micali Salvatore, Karakiewicz Pierre I
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
Department of Urology, AOU di Modena, University of Modena and Reggio Emilia, Modena, Italy.
Ann Surg Oncol. 2025 Mar;32(3):2233-2240. doi: 10.1245/s10434-024-16644-4. Epub 2024 Dec 10.
This study aimed to compare adverse in-hospital outcomes in ileal conduit versus neobladder urinary diversion type after radical cystectomy (RC) in contemporary versus historical patients.
Patients were identified within the National Inpatient Sample (NIS 2000-2019). Propensity score matching (PSM; 1:2 ratio) and multivariable logistic regression models (LRMs) were used.
Of 10,533 contemporary (2011-2019) patients, 943 (9.0%) underwent neobladder urinary diversion, while 9590 (91.0%) underwent ileal conduit urinary diversion. Furthermore, of 9742 historical (2010-2019) patients, 932 (9.6%) underwent neobladder urinary diversion and 8810 (90.4%) underwent ileal conduit urinary diversion. After 1:2 PSM, within the contemporary cohort, 943/943 (100%) neobladder versus 1886/9590 (19.6%) ileal conduit patients were included. Similarly, within the historical cohort, 932/932 (100%) neobladder versus 1864/8810 (21.1%) ileal conduit patients were included after PSM. In multivariable LRMs, relative to contemporary neobladder patients, contemporary ileal conduit patients exhibited higher rates of overall postoperative (49.0 vs. 43.6%; multivariable odds ratio [MOR] 1.2), wound (4.2 vs. 2.7%; MOR 1.6), and genitourinary (13.1% vs. 10.0%; MOR 1.3) complications as well as blood transfusions (19.0 vs. 15.6%; MOR 1.3). Conversely, in multivariable LRMs within the historical cohort, no differences were recorded between ileal conduit and neobladder patients.
Unlike historical comparisons between ileal conduit and neobladder patients, where no differences in adverse in-hospital outcomes were recorded, analyses relying on a contemporary patient cohort subject to PSM and multivariable adjustment revealed higher rates of adverse in-hospital outcomes in 4/13 examined categories. This observation should be considered at informed consent.
本研究旨在比较当代和历史患者在根治性膀胱切除术(RC)后,回肠膀胱术与新膀胱尿流改道类型的院内不良结局。
在国家住院患者样本(2000 - 2019年)中识别患者。使用倾向得分匹配(PSM;1:2比例)和多变量逻辑回归模型(LRMs)。
在10533例当代(2011 - 2019年)患者中,943例(9.0%)接受了新膀胱尿流改道,而9590例(91.0%)接受了回肠膀胱术尿流改道。此外,在9742例历史(2010 - 2019年)患者中,932例(9.6%)接受了新膀胱尿流改道,8810例(90.4%)接受了回肠膀胱术尿流改道。在1:2 PSM后,在当代队列中,纳入了943/943(100%)例新膀胱患者与1886/9590(19.6%)例回肠膀胱术患者。同样,在历史队列中,PSM后纳入了932/932(100%)例新膀胱患者与1864/8810(21.1%)例回肠膀胱术患者。在多变量LRMs中,相对于当代新膀胱患者,当代回肠膀胱术患者术后总体(49.0%对43.6%;多变量优势比[MOR] 1.2)、伤口(4.2%对2.7%;MOR 1.6)和泌尿生殖系统(13.1%对10.0%;MOR 1.3)并发症以及输血(19.0%对15.6%;MOR 1.3)的发生率更高。相反,在历史队列的多变量LRMs中,回肠膀胱术和新膀胱患者之间未记录到差异。
与回肠膀胱术和新膀胱患者之间的历史比较不同,历史比较未记录到院内不良结局的差异,而依赖当代患者队列并进行PSM和多变量调整的分析显示,在13个检查类别中的4个类别中,院内不良结局发生率更高。在知情同意时应考虑这一观察结果。